ZHER2 Affibody as a Good Candidate for Detection of Metastatic Prostate Cancer
Avicenna J Med Biotechnol
.
2021 Jul-Sep;13(3):171.
doi: 10.18502/ajmb.v13i3.6366.
Authors
Mahboobeh Nazari
1
,
Ramin Radmanesh
2
Affiliations
1
Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
2
Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
PMID:
34484647
PMCID:
PMC8377404
DOI:
10.18502/ajmb.v13i3.6366
No abstract available